BioBiz Buzz EPISODE ALERT: From the Horse’s Mouth — Inside Pharma’s Most Volatile Year with Mike Ward, Clarivate
🎙️ NEW BioBiz Buzz EPISODE ALERT: “From the Horse’s Mouth — Inside Pharma’s Most Volatile Year”
💥 What a year it’s been. Pharma’s first $1 trillion company. A $400 billion collapse. Mass layoffs, geopolitical upheaval, AI valuations soaring, and a regulatory reset that changes everything for rare disease developers.
In this unmissable episode of #BioBizBuzz, host Jo Shorthouse sits down with Mike Ward, Clarivate’s Global Head of Life Sciences & Healthcare Thought Leadership, fresh from his “Winners & Losers” keynote at One Nucleus’s 25th Genesis conference in London.
🎤 Together they unpack 2025’s defining stories:
🔹 Eli Lilly’s meteoric rise to trillion-dollar status
🔹 Novo Nordisk’s dramatic fall from grace
🔹 Pfizer’s $10B Metsera move and what it signals for obesity R&D
🔹 China’s transformation into an innovation powerhouse
🔹 The FDA’s game-changing “Plausible Mechanism Pathway” for ultra-rare diseases
🔹 Why pharma M&A hasn’t roared back—yet
🏇 If you’ve been wondering who really won (and lost) in the industry’s most turbulent year on record, this is the one episode you can’t miss.
🎧 Listen now wherever you get your podcasts — or catch the full transcript and Genesis presentation highlights at Clarivate and One Nucleus.